Showing results (111-120 of 171) with videos related to
Sort By:
Pageof 18
The Lancet. Oncology|September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trialSamuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.BMC Cancer|June 28, 2018
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experienceDanielle C Glassman, Randze L Palmaira, Christina M Covington, et al.International Journal of Cancer|December 27, 2022
Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomyThomas Boerner, Rebecca A Carr, Meier Hsu, et al.Investigational New Drugs|June 25, 2010
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinomaManish A Shah, Derek G Power, Hedy L Kindler, et al.Cancer|February 10, 2010
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survivalGeoffrey Y Ku, Jianda Yuan, David B Page, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 15, 2018
Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC ExperienceTamar B Nobel, Arianna Barbetta, Meier Hsu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinomaManish A Shah, Ramesh K Ramanathan, David H Ilson, et al.The Oncologist|July 10, 2025
Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case seriesIan Nykaza, Andrea Moy, Stephen W Dusza, et al.Annals of Surgical Oncology|August 12, 2015
Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric AdenocarcinomaDo Joong Park, An Na Seo, Changhwan Yoon, et al.Brachytherapy|February 26, 2013
Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patientsMichael R Folkert, Gil'ad N Cohen, Abraham J Wu, et al.Pageof 18